Danielle Graham

11.6k total citations · 1 hit paper
68 papers, 4.5k citations indexed

About

Danielle Graham is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Danielle Graham has authored 68 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 19 papers in Physiology. Recurrent topics in Danielle Graham's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Alzheimer's disease research and treatments (16 papers) and Neuroscience and Neuropharmacology Research (13 papers). Danielle Graham is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Alzheimer's disease research and treatments (16 papers) and Neuroscience and Neuropharmacology Research (13 papers). Danielle Graham collaborates with scholars based in United States, Japan and France. Danielle Graham's co-authors include David W. Self, Eric J. Nestler, Ralph Dileone, Maribel Rios, Vaishnav Krishnan, Carlos A. Bolaños, Colleen A. McClung, Olivier Berton, Lisa M. Monteggia and William Renthal and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Danielle Graham

60 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress

2006 1.7k citations Ralph Dileone, Danielle Graham et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Graham United States	29	2.0k	1.2k	1.1k	786	739	68	4.5k
Vootele Võikar Finland	34	1.8k 0.9×	1.2k 1.0×	816 0.8×	708 0.9×	771 1.0×	82	4.4k
Alfred J. Robison United States	37	2.3k 1.1×	2.1k 1.7×	939 0.9×	817 1.0×	651 0.9×	81	5.1k
Anne B. Rocher United States	27	1.7k 0.9×	1.3k 1.0×	1.4k 1.3×	598 0.8×	1.5k 2.0×	31	5.4k
Angelika Schmitt Germany	43	2.2k 1.1×	1.7k 1.4×	588 0.5×	544 0.7×	695 0.9×	95	5.0k
Francesco Angelucci Italy	45	2.2k 1.1×	1.2k 0.9×	578 0.5×	399 0.5×	941 1.3×	130	5.7k
Eero Vasar Estonia	44	2.5k 1.3×	2.5k 2.0×	1.2k 1.1×	902 1.1×	1.1k 1.4×	259	6.6k
Wolfgang H. Sommer Germany	46	3.6k 1.8×	1.8k 1.5×	1.1k 1.0×	608 0.8×	814 1.1×	153	6.1k
Annika Thorsell Sweden	41	2.9k 1.5×	1.9k 1.5×	1.2k 1.1×	678 0.9×	828 1.1×	114	5.1k
Vincent Vialou United States	38	2.4k 1.2×	2.1k 1.7×	1.7k 1.5×	1.2k 1.6×	701 0.9×	64	6.1k
Ja Wook Koo South Korea	28	1.6k 0.8×	988 0.8×	1.4k 1.3×	598 0.8×	468 0.6×	57	4.2k

Countries citing papers authored by Danielle Graham

Since Specialization

Citations

This map shows the geographic impact of Danielle Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Graham more than expected).

Fields of papers citing papers by Danielle Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Graham. The network helps show where Danielle Graham may publish in the future.

Co-authorship network of co-authors of Danielle Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Graham. A scholar is included among the top collaborators of Danielle Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Graham. Danielle Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Varma, Sushama, Jack Pengfei Tang, Danielle Graham, et al.. (2025). SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics. Genome Medicine. 17(1). 89–89.

Ferber, Kyle, Erin G. Rosenbaugh, Michael Benatar, et al.. (2025). Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassays. Clinical Chemistry and Laboratory Medicine (CCLM). 64(2). 410–420.

Lane, Roger, Taher Darreh‐Shori, Candice Junge, et al.. (2024). Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers. BMC Neurology. 24(1). 116–116. 2 indexed citations

Aliakbari, Farhang, Emily Truscott, Lynda McCaig, et al.. (2024). A technique for repeated blood and cerebrospinal fluid sampling from individual rats over time without the need for repeated anesthesia. Scientific Reports. 14(1). 5171–5171.

Liu, Yuting, Minhua Yang, Kyle Fraser, et al.. (2024). Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100003–100003. 3 indexed citations

Fogelman, I., Tim West, Joel B. Braunstein, et al.. (2023). Independent study demonstrates amyloid probability score accurately indicates amyloid pathology. Annals of Clinical and Translational Neurology. 10(5). 765–778. 13 indexed citations

Shulman, Melanie, Jessica Kong, John O’Gorman, et al.. (2023). TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease. Nature Aging. 3(12). 1591–1601. 47 indexed citations

Vanbrabant, Jeroen, Steffi De Meyer, Carrie E. Rubel, et al.. (2023). Performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays. Alzheimer s & Dementia. 19(S15). 1 indexed citations

Bora, Pranami, Silvia Parolo, Michael Monine, et al.. (2022). A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen. CPT Pharmacometrics & Systems Pharmacology. 12(2). 196–206. 7 indexed citations

10.

Benatar, Michael, Joanne Wuu, Peter M. Andersen, et al.. (2021). Design of a Phase 3, Randomized, Placebo-controlled Trial of Tofersen Initiated in Clinically Pre-symptomatic SOD1 Mutation Carriers with a Longitudinal Natural History Run-in (2285). Neurology. 96(15_supplement).

11.

Sopko, Richelle, Olga Golonzhka, Joseph W. Arndt, et al.. (2020). Characterization of tau binding by gosuranemab. Neurobiology of Disease. 146. 105120–105120. 44 indexed citations

12.

Bryś, Mirosław, Laura Fanning, Serena Hung, et al.. (2019). Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054. Movement Disorders. 34(8). 1154–1163. 139 indexed citations

13.

Bryś, Mirosław, Aaron Ellenbogen, Laura Fanning, et al.. (2018). Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Anti-Alpha-Synuclein Antibody BIIB054 in Patients with Parkinson’s Disease (S26.001). Neurology. 90(15_supplement). 17 indexed citations

14.

Souza, Adriano L.S., Rui Chang, Shuning Huang, et al.. (2018). ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs. Neurology and Therapy. 7(1). 103–128. 10 indexed citations

15.

Ravikumar, Brinda, Daniel K. Crawford, Tammy Dellovade, et al.. (2016). Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis. Neuropharmacology. 108. 229–237. 40 indexed citations

16.

Graham, Danielle, Audrey Gray, John A. Joyce, et al.. (2013). Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology. 79. 307–313. 89 indexed citations

17.

Graham, Danielle & David W. Self. (2010). Integrating Behavioral and Molecular Approaches in Mouse: Self-Administration Studies. 163–192. 2 indexed citations

18.

Larson, Erin B., Fatih Akkentli, Scott Edwards, et al.. (2010). Striatal regulation of ΔFosB, FosB, and cFos during cocaine self‐administration and withdrawal. Journal of Neurochemistry. 115(1). 112–122. 67 indexed citations

19.

Graham, Danielle, Scott Edwards, Ryan K. Bachtell, et al.. (2007). Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nature Neuroscience. 10(8). 1029–1037. 329 indexed citations

20.

Edwards, Scott, Danielle Graham, Ryan K. Bachtell, & David W. Self. (2007). Region‐specific tolerance to cocaine‐regulated cAMP‐dependent protein phosphorylation following chronic self‐administration. European Journal of Neuroscience. 25(7). 2201–2213. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact